ALEC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALEC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2025-03-15), the Trailing Annual Dividend Yield of Alector is 0.00%.
The historical rank and industry rank for Alector's Dividend Yield % or its related term are showing as below:
Alector's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00.
As of today (2025-03-15), the Forward Dividend Yield % of Alector is 0.00%.
Alector's Dividends per Share for the three months ended in Dec. 2024 was $0.00.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
The historical data trend for Alector's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alector Annual Data | |||||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||||||
Dividend Yield % | Get a 7-Day Free Trial |
![]() |
- | - | - | - | - |
Alector Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Dividend Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Biotechnology subindustry, Alector's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Alector's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Alector's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Alector (NAS:ALEC) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.
Thank you for viewing the detailed overview of Alector's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sara Kenkare-mitra | officer: President and Head of R&D | C/O ALECTOR, INC, 131 OYSTER POINT BLVD, SUITE 600, SOUTH SAN FRANCISCO CA 94080 |
Gary Romano | officer: Chief Medical Officer | TWO COMMERCE SQUARE, 2001 MARKET STREET, 28TH FLOOR, PHILADELPHIA PA 19103 |
Arnon Rosenthal | director, officer: Chief Executive Officer | C/O ALECTOR, INC., 151 OYSTER POINT BLVD., #300, SOUTH SAN FRANCISCO CA 94080 |
Marc Grasso | officer: Chief Financial Officer | C/O KURA ONCOLOGY, INC., 3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO CA 92121 |
Richard H Scheller | director | C/O GENENTECH INC, 1 DNA WAY MS 49, SOUTH SAN FRANCISCO CA 94080-4990 |
Paula Hammond | director | C/O ALECTOR, INC., 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA 94080 |
Kristine Yaffe | director | C/O ALECTOR, INC., 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO CA 94080 |
Polaris Venture Management Co. Vi, L.l.c. | 10 percent owner | ONE MARINA PARK DRIVE, 8TH FLOOR, BOSTON MA 02210 |
Terrance Mcguire | director, 10 percent owner | C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154 |
Elizabeth A. Garofalo | director | C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO CA 92130 |
David M. Wehner | director | C/O FACEBOOK, INC., 1601 WILLOW ROAD, MENLO PARK CA 94025 |
Tillman U. Gerngross | director | C/O ARSANIS, INC., 890 WINTER STREET, SUITE 230, WALTHAM MA 02451 |
Lavigne Louis J Jr | director | C/O ALLERGAN, INC., 2525 DUPONT DRIVE, IRVINE CA 92612 |
Robert King | officer: Chief Development Officer | 950 TOWER LANE, SUITE 900, FOSTER CITY CA 94404 |
Shehnaaz Suliman | officer: President and COO | 901 GATEWAY BLVD, SOUTH SAN FRANCISCO CA 94080 |
From GuruFocus
By GuruFocus News • 11-07-2024
By Marketwired • 02-19-2025
By GuruFocus Research • 08-23-2024
By Marketwired • 07-28-2024
By GuruFocus Research • 08-07-2024
By GuruFocus News • 10-08-2024
By Marketwired • 07-31-2024
By Marketwired • 06-20-2024
By GuruFocus Research • 08-09-2024
By Marketwired • 01-13-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.